|
Name |
1-Chlorooctadecane
|
Molecular Formula | C18H37Cl | |
IUPAC Name* |
1-chlorooctadecane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCl
|
|
InChI |
InChI=1S/C18H37Cl/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h2-18H2,1H3
|
|
InChIKey |
VUQPJRPDRDVQMN-UHFFFAOYSA-N
|
|
Synonyms |
1-CHLOROOCTADECANE; 3386-33-2; Octadecyl chloride; Octadecane, 1-chloro-; n-Octadecyl chloride; Stearyl chloride; Chlorooctadecane; Octadecane, chloro-; 73H8VD533I; NSC-5543; 1-Chloroctadecane; NSC 5543; EINECS 222-207-7; chloroctadecyl; stearylchloride; UNII-73H8VD533I; AI3-28591; 1-chloro-octadecane; 1-chloranyloctadecane; DSSTox_CID_7536; 1-Chlorooctadecane, 96%; EC 222-207-7; SCHEMBL7496; 1-OCTADECYL CHLORIDE; DSSTox_RID_78494; DSSTox_GSID_27536; CHEMBL3187568; DTXSID3027536; NSC5543; J595I; Tox21_202998; MFCD00000960; ZINC60003888; AKOS009031592; 1-Chlorooctadecane, analytical standard; CS-W014556; NCGC00260543-01; CAS-3386-33-2; DB-048506; FT-0634816; EN300-19888; A821964; J-504534; Q27266182; 1-Chlorooctadecane 10000 microg/mL in Dichloromethane
|
|
CAS | 3386-33-2 | |
PubChem CID | 18815 | |
ChEMBL ID | CHEMBL3187568 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 288.9 | ALogp: | 10.1 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.202 |
Caco-2 Permeability: | -4.849 | MDCK Permeability: | 0.00000815 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.037 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.022 | Plasma Protein Binding (PPB): | 99.31% |
Volume Distribution (VD): | 4.499 | Fu: | 1.22% |
CYP1A2-inhibitor: | 0.149 | CYP1A2-substrate: | 0.177 |
CYP2C19-inhibitor: | 0.294 | CYP2C19-substrate: | 0.06 |
CYP2C9-inhibitor: | 0.072 | CYP2C9-substrate: | 0.953 |
CYP2D6-inhibitor: | 0.317 | CYP2D6-substrate: | 0.062 |
CYP3A4-inhibitor: | 0.18 | CYP3A4-substrate: | 0.042 |
Clearance (CL): | 4.34 | Half-life (T1/2): | 0.077 |
hERG Blockers: | 0.244 | Human Hepatotoxicity (H-HT): | 0.039 |
Drug-inuced Liver Injury (DILI): | 0.55 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.056 | Maximum Recommended Daily Dose: | 0.041 |
Skin Sensitization: | 0.949 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.99 | Eye Irritation: | 0.966 |
Respiratory Toxicity: | 0.819 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000428 | 0.833 | D00AOJ | 0.694 | ||||
ENC000429 | 0.833 | D07ILQ | 0.597 | ||||
ENC000521 | 0.833 | D00FGR | 0.548 | ||||
ENC000284 | 0.833 | D0Z5SM | 0.535 | ||||
ENC000285 | 0.794 | D05ATI | 0.457 | ||||
ENC000745 | 0.794 | D0O1PH | 0.440 | ||||
ENC000400 | 0.783 | D00STJ | 0.420 | ||||
ENC000486 | 0.783 | D0T9TJ | 0.354 | ||||
ENC000262 | 0.773 | D0P1RL | 0.340 | ||||
ENC001124 | 0.769 | D00MLW | 0.324 |